Capio has signed an agreement to acquire all shares in Globen Ögonklinik through the parent company PanSyn Sweden AB (the transaction is subject to approval by Stockholm County Council). The clinic is specialised in ophthalmology and offers complex eye treatments, including cataract surgery, RLE (Refractive Lens Exchange) and refractive laser treatments. Globen Ögonklinik provides ophthalmology treatments at two locations in the southern part of Stockholm and performs annually about 36,000 consultations and 4,600 surgeries. The clinic serves both public and private pay patients, with its main focus being on supporting the public healthcare system.
Globen Ögonklinik will be included in Capio Medocular, which is part of the business area Capio Specialist Clinics. Capio Medocular was founded in 1986 and is today one of the largest private companies within ophthalmology treatments in the Nordics, specialised in general eye care, cataract surgery and treatment of sight disorders.
The Capio Group is a leading, pan-European healthcare provider offering a broad range of high quality medical, surgical and psychiatric healthcare services through its hospitals, specialist clinics and primary care units. In 2016, Capio’s 12,435 employees provided healthcare services during 4.7 million patient visits across the Group’s facilities in Sweden, Norway, Denmark, France and Germany, generating net sales of MSEK 14,069. Capio AB (publ) is listed on Nasdaq Stockholm.
Capio was advised by Mannheimer Swartling in the transaction.